People in the combination SGLT2i with dulaglutide group had 1.43, 1.68, and 1.61 kg greater reductions in weight from baseline at 6, 12, and 18 months, respectively
The high-dose group also lost 28% of body weight after eight months, while the low-dose group lost 24%
Work in the authors laboratory was supported by funds from Karolinska Institutet, the Swedish Research Council, the Family Erling-Persson Foundation, the Novo Nordisk Foundation, the Stichting af Jochnick Foundation, the Swedish Diabetes Association, Scandia Insurance Company Limited, the Diabetes Research and Wellness Foundation, the Berth von Kantzows Foundation, the Strategic Research Program in Diabetes at Karolinska Institutet, the European Research Council grant ERC-2018-AdG834860EYELETS, the Swedish Foundation for Strategic Research and the Knut and Alice Wallenberg Foundation
A new study examined short-term changes in food noise in a digital behavioral weight management program both with and without GLP-1 drugs
As COVID-19 lacks definitive treatment so far, patients with diabetes mellitus should follow general preventive rules strictly and monitor glucose levels more frequently, engage in physical activity, eat healthily and control other risk factors
The major share of the segment mainly attributed to The availability of biosimilars at a lower price than originator biologics and the growing prevalence of cancer globally are expected to drive the growth of the oncology segment